Mechanisms of acute lung injury from blood transfusions.

输血引起的急性肺损伤的机制。

• 批准号: 8845595
• 负责人: MARK ROBERTS LOONEY
• 金额: $ 39.82万
• 依托单位: UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
• 依托单位国家: 美国
• 财政年份: 2011
• 资助国家: 美国
• 起止时间: 2011-04-01 至 2017-03-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8845595
• 关键词: Acute; Acute Lung Injury; Affect; Aspirin; Award; Blood Platelets; Blood Transfusion; Blood Vessels; Bone Marrow; Cause of Death; Cells; Chimera organism; Data; Deoxyribonucleases; Dependency; Development; Dyes; Endothelium; Event; Fc Receptor; Histones; Human; Image; Immunologics; In Vitro; Injury; Investigation; Knock-out; Knockout Mice; Laser Microscopy; Lead; Leukocyte Elastase; Leukocytes; Life; Lung; MHC Class I Genes; Matrix Metalloproteinases; Microcirculation; Microscopy; Modeling; Molecular; Monoclonal Antibodies; Mouse Protein; Mus; Pathogenesis; Peptide Hydrolases; Permeability; Plasma; Platelet Activation; Platelet Inhibitors; Process; Production; Proteins; Pulmonary Edema; Reactive Oxygen Species; Risk; Role; Severities; Surface; Testing; Time; Transfusion; Transgenic Organisms; United States; Vascular Permeabilities; Wild Type Mouse; base; clopidogrel; extracellular; in vivo; inhibitor/antagonist; injured; intravital microscopy; loss of function mutation; lung injury; mortality; mouse model; neutralizing antibody; neutrophil; novel; peripheral blood; receptor; receptor expression; spatial relationship; tirofiban; two-photon

DESCRIPTION (provided by applicant): One of the major non-infectious risks from blood transfusions is the development of transfusion-related acute lung injury (TRALI), which is the number one cause of transfusion-related mortality in the United States. We have previously shown in a mouse model of TRALI that neutrophils and platelets are both required to produce acute lung endothelial injury, protein permeability, and pulmonary edema. However, the mechanisms by which neutrophils and platelets potentially interact and ultimately lead to lung injury are not known. In this application, we will test potential mechanisms in three scientific aims. In Aim 1, we will test for the presence of neutrophil-platelet aggregates in TRALI and determine the molecular mechanisms responsible for the aggregates by using bone marrow chimeras and in vitro studies with cells isolated from MHC Class I-null mice and Fcg receptor knockouts. We will also test pharmacologic inhibitors of platelets and the mechanisms by which these inhibitors may ameliorate lung injury. In Aim 2, we will determine how neutrophils lead to lung endothelial injury by using mice with loss of function mutations in neutrophil proteases and ROS production. We hypothesize that neutrophil extracellular traps (NETs) will be formed in TRALI in a platelet-dependent process that exposes extracellular histones leading to lung endothelial injury. In Aim 3, we will use a new application of two-photon microscopy in the live, mouse lung to image the temporal sequence of neutrophil and platelet recruitment in our mouse model of TRALI. Using intravital microscopy, we will also determine the spatial relationships between neutrophils and platelets in the injured lung and how this influences NET formation in the lung microvasculature. The results from this investigation will elucidate the mechanisms of lung injury in TRALI, and by focusing on the roles of platelet activation and NET formation it may be possible to identify novel pharmacologic approaches to treating acute lung injury.

描述（由申请人提供）：输血带来的主要非传染性风险之一是发生输血相关急性肺损伤（TRALI），这是美国输血相关死亡的第一大原因。我们之前在 TRALI 小鼠模型中表明，中性粒细胞和血小板都是产生急性肺内皮损伤、蛋白质通透性和肺水肿所必需的。然而，中性粒细胞和血小板潜在相互作用并最终导致肺损伤的机制尚不清楚。在此应用中，我们将测试三个科学目标的潜在机制。在目标 1 中，我们将测试 TRALI 中是否存在中性粒细胞-血小板聚集体，并通过使用骨髓嵌合体以及对从 MHC I 类缺失小鼠和 Fcg 受体敲除小鼠中分离的细胞进行体外研究来确定导致聚集的分子机制。我们还将测试血小板的药理学抑制剂以及这些抑制剂改善肺损伤的机制。在目标 2 中，我们将通过使用中性粒细胞蛋白酶和 ROS 产生功能缺失突变的小鼠来确定中性粒细胞如何导致肺内皮损伤。我们假设 TRALI 中将通过血小板依赖性过程形成中性粒细胞胞外陷阱 (NET)，该过程暴露胞外组蛋白，导致肺内皮损伤。在目标 3 中，我们将在小鼠活体肺中使用双光子显微镜的新应用，对 TRALI 小鼠模型中中性粒细胞和血小板募集的时间序列进行成像。使用活体显微镜，我们还将确定受损肺中中性粒细胞和血小板之间的空间关系，以及这如何影响肺微脉管系统中 NET 的形成。这项研究的结果将阐明 TRALI 肺损伤的机制，并且通过关注血小板活化和 NET 形成的作用，有可能确定治疗急性肺损伤的新药理学方法。